The present study was undertaken to determine the beneficial effect of a prolonged treatment (1 week) with the centrally and peripherally acting B1R antagonist SSR240612 on the main features and complications of diabetes in high glucose feeding. The gene discussed is BDKRB1; the disease is diabetes mellitus.